Symbols / CCRN Stock $10.20 -0.97% Cross Country Healthcare, Inc.

Healthcare • Medical Care Facilities • United States • NMS
CCRN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. Kevin Cronin Clark
Exch · Country NMS · United States
Market Cap 328.43M
Enterprise Value 223.23M
Income -94.85M
Sales 1.05B
FCF (ttm) 42.77M
Book/sh 10.18
Cash/sh 3.37
Employees 7,890
Insider 10d —
IPO Oct 25, 2001
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 36.43
PEG 8.74
P/S 0.31
P/B 1.00
P/C —
EV/EBITDA 12.05
EV/Sales 0.21
Quick Ratio 3.61
Current Ratio 3.78
Debt/Eq 0.72
LT Debt/Eq —
EPS (ttm) -2.93
EPS next Y 0.28
EPS Growth —
Revenue Growth -23.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-03-04
ROA 0.31%
ROE -25.57%
ROIC —
Gross Margin 20.26%
Oper. Margin -0.62%
Profit Margin -9.00%
Shs Outstand 32.20M
Shs Float 29.77M
Insider Own 7.43%
Instit Own 83.54%
Short Float 3.77%
Short Ratio 2.92
Short Interest 1.14M
52W High 14.99
vs 52W High -31.95%
52W Low 7.43
vs 52W Low 37.28%
Beta 0.34
Impl. Vol. 1.43%
Rel Volume 0.43
Avg Volume 467.48K
Volume 200.38K
Target (mean) $11.67
Tgt Median $10.50
Tgt Low $10.00
Tgt High $15.00
# Analysts 6
Recom Buy
Prev Close $10.30
Price $10.20
Change -0.97%
About

Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel nurse and allied professionals, per diem, and healthcare leaders within nursing, allied, human resources, and finance; vendor neutral and managed services programs; and education healthcare, caregiver services, and outsourcing services. This segment offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term assignments, as well as workforce solutions, including MSP, VMS, RPO, project management, and other outsourcing and consultative services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. The company serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, correctional facilities, PACE programs, physician practice groups, and other healthcare providers. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments. This segment serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$11.67
Mean price target
2. Current target
$10.20
Latest analyst target
3. DCF / Fair value
$23.91
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.20
Low
$10.00
High
$15.00
Mean
$11.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-19 up Wedbush Neutral → Outperform $15
2026-03-05 up Benchmark Hold → Buy $14
2026-02-03 init Wedbush — → Neutral $11
2025-12-09 main UBS Neutral → Neutral $9
2025-06-17 main Barrington Research Market Perform → Market Perform $19
2025-05-13 main UBS Neutral → Neutral $17
2025-03-14 main Barrington Research Market Perform → Market Perform $19
2025-02-06 reit JMP Securities Market Perform → Market Perform —
2024-12-10 down Barrington Research Outperform → Market Perform —
2024-12-05 main Truist Securities Hold → Hold $19
2024-11-07 main Benchmark Buy → Buy $18
2024-10-21 main Truist Securities Hold → Hold $15
2024-08-08 main Barrington Research Outperform → Outperform $19
2024-08-01 main Truist Securities Hold → Hold $17
2024-05-06 main Barrington Research Outperform → Outperform $21
2024-05-02 main Benchmark Buy → Buy $19
2024-02-27 main Barrington Research Outperform → Outperform $24
2024-02-22 main Truist Securities Hold → Hold $16
2024-02-22 main Benchmark Buy → Buy $21
2023-12-06 init JMP Securities — → Market Perform —
News
RSS: Latest CCRN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-31 BALL SUSAN E General Counsel — 33,644 $0.00 $0
2026-03-31 BURNS WILLIAM J. Chief Financial Officer — 47,873 $0.00 $0
2026-03-31 CLARK KEVIN CRONIN Chief Executive Officer — 138,963 $0.00 $0
2026-03-31 KRUG MARC S Officer — 21,024 $0.00 $0
2026-03-31 HAWKINS AMIEE LIN Chief Operating Officer — 15,958 $0.00 $0
2026-03-31 VEIZAGA MARVIN Officer — 9,043 $0.00 $0
2026-03-11 MCDONALD COLIN PATRICK Officer — 6,200 $9.70 $60,146
2025-12-18 BALL SUSAN E General Counsel — 35,804 $0.00 $0
2025-12-18 CASH WILLIAM LARRY Director — 18,680 $0.00 $0
2025-12-18 FITZGERALD GALE S Director — 18,680 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,054.29
-21.56%
1,344.00
-33.46%
2,019.73
-27.95%
2,803.38
Operating Revenue
1,054.29
-21.56%
1,344.00
-33.46%
2,019.73
-27.95%
2,803.38
Cost Of Revenue
840.72
-21.41%
1,069.75
-31.83%
1,569.32
-27.98%
2,178.92
Reconciled Cost Of Revenue
840.72
-21.41%
1,069.75
-31.83%
1,569.32
-27.98%
2,178.92
Gross Profit
213.57
-22.13%
274.25
-39.11%
450.41
-27.87%
624.46
Operating Expense
—
—
318.68
—
Selling General And Administration
200.68
-14.01%
233.38
-22.29%
300.33
-7.36%
324.21
Total Expenses
1,058.20
-19.91%
1,321.33
-30.01%
1,888.00
-24.95%
2,515.71
Operating Income
-3.90
-117.21%
22.68
-82.79%
131.73
-54.21%
287.67
Total Operating Income As Reported
-84.41
-400.53%
-16.86
-114.96%
112.71
-58.24%
269.88
EBITDA
-64.50
-1716.54%
3.99
-96.91%
129.34
-53.82%
280.06
Normalized EBITDA
16.01
-63.22%
43.53
-70.99%
150.08
-50.24%
301.58
Reconciled Depreciation
16.79
-7.73%
18.20
-0.80%
18.35
+45.89%
12.58
EBIT
-81.29
-472.09%
-14.21
-112.80%
110.99
-58.51%
267.49
Total Unusual Items
—
—
-20.74
—
Total Unusual Items Excluding Goodwill
-80.51
-103.62%
-39.54
-90.64%
-20.74
+3.62%
-21.52
Special Income Charges
-80.51
-103.62%
-39.54
-90.64%
-20.74
+3.62%
-21.52
Other Special Charges
2.75
-58.77%
6.67
+134.13%
2.85
-23.61%
3.73
Impairment Of Capital Assets
77.85
+2595.67%
2.89
+301.67%
0.72
-87.15%
5.60
Restructuring And Mergern Acquisition
0.35
-95.88%
8.55
+227.41%
2.61
+0.97%
2.59
Write Off
-0.44
-102.06%
21.43
+47.18%
14.56
+51.55%
9.61
Net Income
-94.85
-551.64%
-14.56
-120.04%
72.63
-60.95%
185.98
Pretax Income
-83.51
-409.27%
-16.40
-115.94%
102.89
-59.35%
253.10
Net Non Operating Interest Income Expense
0.91
+761.59%
-0.14
+98.28%
-8.01
+44.29%
-14.38
Interest Expense Non Operating
2.22
+1.28%
2.19
-72.97%
8.09
-43.76%
14.39
Net Interest Income
0.91
+761.59%
-0.14
+98.28%
-8.01
+44.29%
-14.38
Interest Expense
2.22
+1.28%
2.19
-72.97%
8.09
-43.76%
14.39
Interest Income Non Operating
3.13
+52.63%
2.05
+2369.88%
0.08
+730.00%
0.01
Interest Income
3.13
+52.63%
2.05
+2369.88%
0.08
+730.00%
0.01
Other Income Expense
-80.52
-106.81%
-38.94
-86.95%
-20.83
-3.12%
-20.20
Other Non Operating Income Expenses
-0.01
-101.49%
0.60
+811.76%
-0.09
-106.41%
1.33
Tax Provision
11.34
+715.74%
-1.84
-106.09%
30.26
-54.91%
67.11
Tax Rate For Calcs
0.00
+87.00%
0.00
-61.82%
0.00
+10.98%
0.00
Tax Effect Of Unusual Items
-16.91
-280.77%
-4.44
+27.21%
-6.10
-6.96%
-5.70
Net Income Including Noncontrolling Interests
-94.85
-551.64%
-14.56
-120.04%
72.63
-60.95%
185.98
Net Income From Continuing Operation Net Minority Interest
-94.85
-551.64%
-14.56
-120.04%
72.63
-60.95%
185.98
Net Income From Continuing And Discontinued Operation
-94.85
-551.64%
-14.56
-120.04%
72.63
-60.95%
185.98
Net Income Continuous Operations
-94.85
-551.64%
-14.56
-120.04%
72.63
-60.95%
185.98
Minority Interests
—
—
—
0.00
Normalized Income
-31.25
-252.11%
20.54
-76.46%
87.27
-56.75%
201.80
Net Income Common Stockholders
-94.85
-551.64%
-14.56
-120.04%
72.63
-60.95%
185.98
Diluted EPS
-2.93
-565.91%
-0.44
-121.46%
2.05
-59.16%
5.02
Basic EPS
-2.93
-565.91%
-0.44
-121.26%
2.07
-59.33%
5.09
Basic Average Shares
32.41
-2.91%
33.38
-5.06%
35.16
-5.01%
37.01
Diluted Average Shares
32.41
-2.91%
33.38
-5.91%
35.48
-5.49%
37.54
Diluted NI Availto Com Stockholders
-94.85
-551.64%
-14.56
-120.04%
72.63
-60.95%
185.98
Depreciation Amortization Depletion Income Statement
16.79
-7.73%
18.20
-0.80%
18.35
+45.89%
12.58
Depreciation And Amortization In Income Statement
16.79
-7.73%
18.20
-0.80%
18.35
+45.89%
12.58
Provision For Doubtful Accounts
—
21.43
+47.18%
14.56
+51.55%
9.61
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
448.95
-23.81%
589.25
-13.48%
681.06
-28.15%
947.84
Current Assets
293.59
-12.36%
335.00
-19.64%
416.88
-38.30%
675.67
Cash Cash Equivalents And Short Term Investments
108.74
+33.20%
81.63
+377.55%
17.09
+374.31%
3.60
Cash And Cash Equivalents
108.74
+33.20%
81.63
+377.55%
17.09
+374.31%
3.60
Receivables
175.96
-27.55%
242.88
-37.73%
390.07
-40.90%
659.96
Accounts Receivable
167.51
-24.96%
223.24
-40.05%
372.35
-41.97%
641.61
Gross Accounts Receivable
176.62
-24.05%
232.54
-40.81%
392.90
-40.13%
656.31
Allowance For Doubtful Accounts Receivable
-9.11
+2.03%
-9.30
+54.73%
-20.55
-39.81%
-14.70
Other Receivables
4.85
-47.59%
9.26
+1.74%
9.10
+22.37%
7.43
Taxes Receivable
3.59
-65.41%
10.39
+20.52%
8.62
-21.03%
10.91
Prepaid Assets
7.56
-3.66%
7.85
+2.17%
7.68
-30.60%
11.07
Other Current Assets
1.33
-49.45%
2.64
+29.84%
2.03
+94.91%
1.04
Total Non Current Assets
155.36
-38.89%
254.25
-3.76%
264.19
-2.93%
272.17
Net PPE
29.98
-4.27%
31.32
+4.61%
29.94
+30.58%
22.93
Gross PPE
56.00
+10.67%
50.60
+10.62%
45.75
+12.65%
40.61
Accumulated Depreciation
-26.02
-34.92%
-19.29
-22.00%
-15.81
+10.60%
-17.68
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
45.87
-1.64%
46.64
+13.92%
40.94
+31.06%
31.24
Construction In Progress
7.87
+595.76%
1.13
+13.33%
1.00
-71.17%
3.46
Other Properties
2.21
-10.62%
2.47
-5.04%
2.60
-20.40%
3.27
Leases
0.06
-85.05%
0.37
-69.64%
1.21
-54.20%
2.65
Goodwill And Other Intangible Assets
91.44
-48.41%
177.25
-6.66%
189.90
-8.70%
207.99
Goodwill
63.80
-52.76%
135.06
-0.27%
135.43
-17.05%
163.27
Other Intangible Assets
27.64
-34.49%
42.19
-22.55%
54.47
+21.79%
44.72
Non Current Accounts Receivable
14.86
-29.00%
20.93
-18.61%
25.71
+11.52%
23.06
Non Current Deferred Assets
2.94
-73.27%
10.99
+18.50%
9.28
-3.05%
9.57
Non Current Deferred Taxes Assets
0.00
-100.00%
8.10
+35.54%
5.98
-15.69%
7.09
Non Current Prepaid Assets
1.01
-5.36%
1.06
+47.64%
0.72
-0.55%
0.72
Other Non Current Assets
15.02
+18.71%
12.65
+46.96%
8.61
+9.03%
7.90
Total Liabilities Net Minority Interest
126.13
-25.93%
170.29
-20.21%
213.41
-56.50%
490.62
Current Liabilities
77.76
-35.42%
120.40
-22.86%
156.08
-42.54%
271.64
Payables And Accrued Expenses
59.27
-33.81%
89.55
-25.29%
119.86
-47.08%
226.49
Payables
34.63
-49.18%
68.14
-34.43%
103.92
-47.89%
199.43
Accounts Payable
2.04
-64.42%
5.74
+88.95%
3.04
-76.37%
12.86
Other Payable
19.34
-48.81%
37.79
-48.82%
73.84
-49.28%
145.59
Current Accrued Expenses
24.65
+15.10%
21.41
+34.28%
15.95
-41.07%
27.06
Employee Benefits
15.77
+2.72%
15.36
+3.76%
14.80
+0.67%
14.70
Pensionand Other Post Retirement Benefit Plans Current
15.14
-34.30%
23.04
-8.77%
25.25
-20.13%
31.62
Total Tax Payable
13.24
-46.19%
24.61
-9.01%
27.04
-34.02%
40.98
Income Tax Payable
—
—
—
0.02
Current Debt And Capital Lease Obligation
1.16
-44.33%
2.09
-19.78%
2.60
-36.98%
4.13
Current Debt
—
—
—
—
Other Current Borrowings
—
—
—
—
Current Capital Lease Obligation
1.16
-44.33%
2.09
-19.78%
2.60
-36.98%
4.13
Other Current Liabilities
2.18
-61.88%
5.72
-31.51%
8.35
-11.10%
9.40
Total Non Current Liabilities Net Minority Interest
48.37
-3.04%
49.89
-12.99%
57.34
-73.82%
218.98
Long Term Debt And Capital Lease Obligation
1.16
-35.19%
1.78
-33.08%
2.66
-98.27%
153.62
Long Term Debt
—
—
—
148.74
Long Term Capital Lease Obligation
1.16
-35.19%
1.78
-33.08%
2.66
-45.43%
4.88
Defined Pension Benefit
0.12
+138.00%
0.05
+56.25%
0.03
0.00
Non Current Deferred Liabilities
5.11
+46.39%
3.49
-6.73%
3.74
+35.95%
2.75
Non Current Deferred Taxes Liabilities
2.52
+345.58%
0.57
+41.15%
0.40
+62.35%
0.25
Other Non Current Liabilities
12.08
+18.52%
10.19
-36.61%
16.08
-39.85%
26.73
Stockholders Equity
322.82
-22.95%
418.96
-10.41%
467.65
+2.28%
457.22
Common Stock Equity
322.82
-22.95%
418.96
-10.41%
467.65
+2.28%
457.22
Capital Stock
0.00
+0.00%
0.00
-25.00%
0.00
+0.00%
0.00
Common Stock
0.00
+0.00%
0.00
-25.00%
0.00
+0.00%
0.00
Share Issued
31.72
-1.72%
32.28
-6.13%
34.38
-5.28%
36.30
Ordinary Shares Number
31.72
-1.72%
32.28
-6.13%
34.38
-5.28%
36.30
Additional Paid In Capital
201.17
-0.58%
202.34
-14.41%
236.42
-19.28%
292.88
Retained Earnings
123.21
-43.50%
218.06
-6.26%
232.62
+40.36%
165.73
Gains Losses Not Affecting Retained Earnings
-1.56
-8.26%
-1.44
-4.04%
-1.39
+0.14%
-1.39
Minority Interest
—
—
—
—
Other Equity Adjustments
-1.56
-8.26%
-1.44
-4.04%
-1.39
+0.14%
-1.39
Total Equity Gross Minority Interest
322.82
-22.95%
418.96
-10.41%
467.65
+2.28%
457.22
Total Capitalization
322.82
-22.95%
418.96
-10.41%
467.65
-22.82%
605.95
Working Capital
215.83
+0.58%
214.60
-17.72%
260.80
-35.45%
404.03
Invested Capital
322.82
-22.95%
418.96
-10.41%
467.65
-22.82%
605.95
Total Debt
2.32
-40.12%
3.87
-26.50%
5.27
-96.66%
157.75
Net Debt
—
—
—
145.13
Capital Lease Obligations
2.32
-40.12%
3.87
-26.50%
5.27
-41.56%
9.01
Net Tangible Assets
231.38
-4.27%
241.71
-12.98%
277.75
+11.45%
249.23
Tangible Book Value
231.38
-4.27%
241.71
-12.98%
277.75
+11.45%
249.23
Non Current Accrued Expenses
14.26
-25.24%
19.07
-4.91%
20.05
-5.32%
21.18
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
48.25
-59.83%
120.12
-51.66%
248.50
+85.38%
134.05
Cash Flow From Continuing Operating Activities
48.25
-59.83%
120.12
-51.66%
248.50
+85.38%
134.05
Net Income From Continuing Operations
-94.85
-551.64%
-14.56
-120.04%
72.63
-60.95%
185.98
Depreciation And Amortization
16.79
-7.73%
18.20
-0.80%
18.35
+45.89%
12.58
Other Non Cash Items
1.78
+63.15%
1.09
-53.83%
2.36
+15.32%
2.05
Stock Based Compensation
7.14
+18.57%
6.03
-8.42%
6.58
-11.01%
7.39
Provisionand Write Offof Assets
-1.00
-104.81%
20.79
+19.78%
17.36
+13.22%
15.33
Asset Impairment Charge
77.85
+2595.67%
2.89
+301.67%
0.72
-87.15%
5.60
Deferred Tax
—
—
—
5.11
Deferred Income Tax
10.07
+617.90%
-1.94
-249.08%
1.30
-74.48%
5.11
Operating Gains Losses
—
—
1.72
-53.78%
3.73
Change In Working Capital
30.46
-65.23%
87.62
-31.26%
127.48
+222.91%
-103.71
Change In Receivables
56.73
-55.80%
128.33
-48.96%
251.43
+264.09%
-153.23
Changes In Account Receivables
56.73
-55.80%
128.33
-48.96%
251.43
+264.09%
-153.23
Change In Prepaid Assets
-2.33
+53.23%
-4.99
-1961.94%
0.27
+103.88%
-6.92
Change In Payables And Accrued Expense
-34.57
-16.19%
-29.75
+76.50%
-126.61
-252.65%
82.94
Change In Other Working Capital
12.83
+505.05%
-3.17
-146.84%
6.76
+131.39%
-21.55
Change In Other Current Liabilities
-2.19
+21.57%
-2.79
+36.15%
-4.37
+11.91%
-4.96
Investing Cash Flow
-8.16
+6.35%
-8.71
+36.74%
-13.78
+68.60%
-43.87
Cash Flow From Continuing Investing Activities
-8.16
+6.35%
-8.71
+36.74%
-13.78
+68.60%
-43.87
Net PPE Purchase And Sale
-8.16
+6.35%
-8.71
+37.64%
-13.97
-59.05%
-8.79
Purchase Of PPE
-8.16
+6.35%
-8.71
+37.64%
-13.97
-59.05%
-8.79
Capital Expenditure
-8.16
+6.35%
-8.71
+37.64%
-13.97
-59.05%
-8.79
Net Business Purchase And Sale
0.00
0.00
-100.00%
0.20
+100.57%
-35.09
Purchase Of Business
—
0.00
0.00
+100.00%
-35.18
Financing Cash Flow
-13.01
+72.24%
-46.85
+78.82%
-221.24
-152.56%
-87.60
Cash Flow From Continuing Financing Activities
-13.01
+72.24%
-46.85
+78.82%
-221.24
-152.56%
-87.60
Net Issuance Payments Of Debt
0.00
0.00
+100.00%
-150.68
-327.28%
-35.26
Issuance Of Debt
1.45
-91.96%
18.02
-97.50%
720.99
-57.59%
1,700.03
Repayment Of Debt
-1.45
+91.96%
-18.02
+97.93%
-871.67
+49.77%
-1,735.29
Long Term Debt Issuance
1.45
-91.96%
18.02
-97.50%
720.99
-57.59%
1,700.03
Long Term Debt Payments
-1.45
+91.96%
-18.02
+97.93%
-871.67
+49.77%
-1,735.29
Net Long Term Debt Issuance
0.00
0.00
+100.00%
-150.68
-327.28%
-35.26
Short Term Debt Issuance
—
—
720.99
-57.59%
1,700.03
Short Term Debt Payments
—
—
-797.79
+51.13%
-1,632.43
Net Short Term Debt Issuance
—
—
-76.80
-213.61%
67.60
Net Common Stock Issuance
-6.83
+81.69%
-37.31
+35.29%
-57.65
-63.40%
-35.28
Common Stock Payments
-6.83
+81.69%
-37.31
+35.29%
-57.65
-63.40%
-35.28
Repurchase Of Capital Stock
-6.83
+81.69%
-37.31
+35.29%
-57.65
-63.40%
-35.28
Net Other Financing Charges
-6.17
+35.29%
-9.54
+26.12%
-12.91
+24.27%
-17.05
Changes In Cash
27.08
-58.04%
64.55
+378.81%
13.48
+423.17%
2.58
Effect Of Exchange Rate Changes
0.02
+250.00%
-0.01
-275.00%
0.01
+188.89%
-0.01
Beginning Cash Position
81.63
+377.55%
17.09
+374.31%
3.60
+247.88%
1.04
End Cash Position
108.74
+33.20%
81.63
+377.55%
17.09
+374.31%
3.60
Free Cash Flow
40.09
-64.01%
111.40
-52.50%
234.52
+87.22%
125.26
Interest Paid Supplemental Data
1.40
+1.75%
1.37
-81.78%
7.53
-41.41%
12.86
Income Tax Paid Supplemental Data
—
2.43
-88.96%
21.99
-73.48%
82.89
Sale Of Business
0.00
0.00
-100.00%
0.20
+111.70%
0.09
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category